Press release
Global Biopharmaceutical Licensing Market Receives Impetus from Increasing Alliances between Pharma and Biopharma Companies
Request Sample of Research Report: http://bit.ly/2edRJKf
This report not only provides valuable insights into market drivers and restraints, but also enumerates the various strategies adopted by biopharma companies to address challenges and convert them into growth opportunities. In addition, a detailed assessment of key trends pertaining to clinical trials and key therapy areas that have been conspicuous in inter-company alliances are presented herein.
In the company profile section of the report, growth strategies of top companies in the biopharmaceutical licensing market are meticulously evaluated. This section also briefs readers about the product pipelines, recent developments, and financial status of top companies in the biopharma market.
The report points out that the biopharma market has undergone a radical change in terms of the regulatory approach for awarding licensing and for alliances that exist between conventional pharma and biopharma companies. This is due to the diminishing conventional differences between pharmaceutical and biopharmaceutical companies. Earlier known for product development or drug discovery, biopharmaceutical companies are currently actively involved in ensuring the sustainability of their products.
Due to these endeavors, the biopharmaceutical licensing market is witnessing a marked change. Resultantly, a considerable number of companies in the biopharma sector are focusing on narrowing their portfolio and focusing on high-value therapy areas such as infections, inflammatory disease, and oncology. The biopharmaceutical industry is heading towards attaining complex licensing deals that extend ownership of commercialization rights and marketing revenues for license owners.
Presently, due to changes in the licensing statutes of the biopharma industry, large pharmaceutical companies are intending to enter into in-licensing agreements and alliances with biopharmaceutical companies. The intent is to gain access to advancements and new technologies in molecular science. This is expected to emerge as a major reason for the biopharmaceutical licensing market to reach new heights. The new practice of a tie-up between pharmaceutical and biopharmaceutical companies has increased the consolidation within the biopharma industry to gain a competitive advantage over pharmaceutical companies, which have been traditionally dominant.
In the context of alliances between pharma and biopharma companies, takeovers by Big Pharma are a notable phenomenon, with deal values having risen by at least 80% in recent years.
Browse Research Report: http://bit.ly/2epRAP4
Top companies that have a significant presence in the global biopharmaceutical licensing market are Pfizer, Intas Pharmaceuticals Ltd., Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Baxter International, Schering-Plough, Proctor & Gamble, Boehringer Inglheim, Merck & Co., Sanofi, Bristol-Myers Squib, Eli Lilly & Company, Hoffman La-Roche, Genentech, Bayer AG, Novartis, and Abbott Laboratories.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biopharmaceutical Licensing Market Receives Impetus from Increasing Alliances between Pharma and Biopharma Companies here
News-ID: 374987 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Transparency
transparency market research
The global Custom Antibody Market market is estimated to attain a valuation of US$1 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.085% during the forecast period, 2023 to 2033.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading…
Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations…
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use…
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems
Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria.
Industrie 4.0 requires intensified collaboration between various tools and systems. Only when…
eDataCenterAnalyzer Increases Transparency in Data Centers
30 June 2016. Walldorf, Germany. – fluid Operations™ AG (fluidOps), a leader in semantic technologies, today launched eDataCenterAnalyzer™, an app that increases transparency in data centers. With the launch of this app and new releases of its Smart Data Platform Information Workbench™ and cloud management app eCloudManager™, the company has set the cornerstone for the future development of its product portfolio.
eDataCenterAnalyzer combines the full functionality of Information Workbench with innovative…
Transparency across the entire process chain
Leitner Spedition implements best4log-x
• Austrian trucking company uses arvato Systems solution
• End-to-end process management provides higher efficiency
(arvato Systems) Gütersloh / Unterpremstätten – Since the beginning of 2015, the Austrian trucking company Leitner Spedition has been working with the best4log-x transport management system. This SAP-based solution from arvato Systems provides an integrated digital information flow and supports mid-sized companies in achieving a transparent process design. Controlling and Reporting have seen a…
